Literature DB >> 23493085

Metabolic disorders: Breaking the links between inflammation and diabetes.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2013        PMID： 23493085     DOI： 10.1038/nrd3988

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.

Authors:  Stefan Kiechl; Jürgen Wittmann; Andrea Giaccari; Michael Knoflach; Peter Willeit; Aline Bozec; Alexander R Moschen; Giovanna Muscogiuri; Gian Pio Sorice; Trayana Kireva; Monika Summerer; Stefan Wirtz; Julia Luther; Dirk Mielenz; Ulrike Billmeier; Georg Egger; Agnes Mayr; Friedrich Oberhollenzer; Florian Kronenberg; Michael Orthofer; Josef M Penninger; James B Meigs; Enzo Bonora; Herbert Tilg; Johann Willeit; Georg Schett
Journal:  Nat Med       Date:  2013-02-10       Impact factor: 53.440

2.  An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice.

Authors:  Shannon M Reilly; Shian-Huey Chiang; Stuart J Decker; Louise Chang; Maeran Uhm; Martha J Larsen; John R Rubin; Jonathan Mowers; Nicole M White; Irit Hochberg; Michael Downes; Ruth T Yu; Christopher Liddle; Ronald M Evans; Dayoung Oh; Pingping Li; Jerrold M Olefsky; Alan R Saltiel
Journal:  Nat Med       Date:  2013-02-10       Impact factor: 53.440
  2 in total
  7 in total

1.  Beclin 2 negatively regulates innate immune signaling and tumor development.

Authors:  Motao Zhu; Guangtong Deng; Peng Tan; Changsheng Xing; Cuiping Guan; Chongming Jiang; Yinlong Zhang; Bo Ning; Chaoran Li; Bingnan Yin; Kaifu Chen; Yuliang Zhao; Helen Y Wang; Beth Levine; Guangjun Nie; Rong-Fu Wang
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

2.  Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways.

Authors:  Xu-qiang Nie; Huai-hong Chen; Jian-yong Zhang; Yu-jing Zhang; Jian-wen Yang; Hui-jun Pan; Wen-xia Song; Ferid Murad; Yu-qi He; Ka Bian
Journal:  Acta Pharmacol Sin       Date:  2016-03-14       Impact factor: 6.150

3.  Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome.

Authors:  Jayshree Mishra; Raj K Verma; Gianfranco Alpini; Fanyin Meng; Narendra Kumar
Journal:  J Biol Chem       Date:  2015-10-08       Impact factor: 5.157

4.  Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-κB-dependent mechanism.

Authors:  Yan Zhao; Si-jia Chen; Jian-cheng Wang; Hong-xin Niu; Qian-qian Jia; Xiao-wen Chen; Xiao-yan Du; Lu Lu; Bo Huang; Quan Zhang; Yue Chen; Hai-bo Long
Journal:  Oxid Med Cell Longev       Date:  2015-01-12       Impact factor: 6.543

5.  A Single 60 mg Dose of Denosumab Might Improve Hepatic Insulin Sensitivity in Postmenopausal Nondiabetic Severe Osteoporotic Women.

Authors:  Elena Passeri; Stefano Benedini; Elena Costa; Sabrina Corbetta
Journal:  Int J Endocrinol       Date:  2015-03-19       Impact factor: 3.257

6.  Differential Chemokine Signature between Human Preadipocytes and Adipocytes.

Authors:  Rosa Mistica C Ignacio; Carla R Gibbs; Eun-Sook Lee; Deok-Soo Son
Journal:  Immune Netw       Date:  2016-06-17       Impact factor: 6.303

Review 7.  Pattern Recognition Receptor-Mediated Chronic Inflammation in the Development and Progression of Obesity-Related Metabolic Diseases.

Authors:  Lili Yu; Yanhua Li; Cancan Du; Weidong Zhao; Hanxiao Zhang; Yun Yang; Aiping Sun; Xiangfeng Song; Zhiwei Feng
Journal:  Mediators Inflamm       Date:  2019-09-08       Impact factor: 4.711
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.